BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

884 related articles for article (PubMed ID: 26052098)

  • 1. Aicardi-Goutières syndrome and the type I interferonopathies.
    Crow YJ; Manel N
    Nat Rev Immunol; 2015 Jul; 15(7):429-40. PubMed ID: 26052098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferonopathies: a novel set of inborn errors of immunity.
    Crow YJ
    Ann N Y Acad Sci; 2011 Nov; 1238():91-8. PubMed ID: 22129056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Type I interferonopathies].
    Munoz J; Marque M; Dandurand M; Meunier L; Crow YJ; Bessis D
    Ann Dermatol Venereol; 2015 Nov; 142(11):653-63. PubMed ID: 26363997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon in neurological disease-the devil from within.
    Hofer MJ; Campbell IL
    Cytokine Growth Factor Rev; 2013 Jun; 24(3):257-67. PubMed ID: 23548179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferonopathies in pediatric rheumatology.
    Volpi S; Picco P; Caorsi R; Candotti F; Gattorno M
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):35. PubMed ID: 27260006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapies in Aicardi-Goutières syndrome.
    Crow YJ; Vanderver A; Orcesi S; Kuijpers TW; Rice GI
    Clin Exp Immunol; 2014 Jan; 175(1):1-8. PubMed ID: 23607857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Type I Interferonopathies.
    Lee-Kirsch MA
    Annu Rev Med; 2017 Jan; 68():297-315. PubMed ID: 27813875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a better understanding of type I interferonopathies: a brief summary, update and beyond.
    Yu ZX; Song HM
    World J Pediatr; 2020 Feb; 16(1):44-51. PubMed ID: 31377974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dirty Fish Versus Squeaky Clean Mice: Dissecting Interspecies Differences Between Animal Models of Interferonopathy.
    Rutherford HA; Kasher PR; Hamilton N
    Front Immunol; 2020; 11():623650. PubMed ID: 33519829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutieres syndrome.
    Cuadrado E; Jansen MH; Anink J; De Filippis L; Vescovi AL; Watts C; Aronica E; Hol EM; Kuijpers TW
    Brain; 2013 Jan; 136(Pt 1):245-58. PubMed ID: 23365100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-tuning of type I IFN-signaling in microglia--implications for homeostasis, CNS autoimmunity and interferonopathies.
    Goldmann T; Blank T; Prinz M
    Curr Opin Neurobiol; 2016 Feb; 36():38-42. PubMed ID: 26397019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoinflammatory phenotypes in Aicardi-Goutières syndrome with interferon upregulation and serological autoimmune features.
    Sugawara Y; Imai K; Kashimada A; Moriyama K; Baba S; Nishikomori R; Motegi M; Takeuchi Y; Morio T
    J Allergy Clin Immunol; 2018 Mar; 141(3):1135-1138. PubMed ID: 29132962
    [No Abstract]   [Full Text] [Related]  

  • 13. Intracellular Nucleic Acid Detection in Autoimmunity.
    Crowl JT; Gray EE; Pestal K; Volkman HE; Stetson DB
    Annu Rev Immunol; 2017 Apr; 35():313-336. PubMed ID: 28142323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I Interferonopathies: A Clinical Review.
    Wang CS
    Rheum Dis Clin North Am; 2023 Nov; 49(4):741-756. PubMed ID: 37821193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunity.
    Behrendt R; Roers A
    Clin Exp Immunol; 2014 Jan; 175(1):9-16. PubMed ID: 23713592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory myopathy in a patient with Aicardi-Goutières syndrome.
    Tumienė B; Voisin N; Preikšaitienė E; Petroška D; Grikinienė J; Samaitienė R; Utkus A; Reymond A; Kučinskas V
    Eur J Med Genet; 2017 Mar; 60(3):154-158. PubMed ID: 28089741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic interferonopathies: An overview.
    Eleftheriou D; Brogan PA
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):441-459. PubMed ID: 29773266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi-Goutières Syndrome, a Type I Interferonopathy.
    Meesilpavikkai K; Dik WA; Schrijver B; van Helden-Meeuwsen CG; Versnel MA; van Hagen PM; Bijlsma EK; Ruivenkamp CAL; Oele MJ; Dalm VASH
    Arthritis Rheumatol; 2019 May; 71(5):829-831. PubMed ID: 30666809
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromyelitis optica in a child with Aicardi-Goutières syndrome.
    Hacohen Y; Zuberi S; Vincent A; Crow YJ; Cordeiro N
    Neurology; 2015 Jul; 85(4):381-3. PubMed ID: 26136517
    [No Abstract]   [Full Text] [Related]  

  • 20. Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient.
    Olivieri I; Cattalini M; Tonduti D; La Piana R; Uggetti C; Galli J; Meini A; Tincani A; Moratto D; Fazzi E; Balottin U; Orcesi S
    Lupus; 2013 Sep; 22(10):1064-9. PubMed ID: 23918923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.